Key result
POLARx cryoballoon achieves 100% acute pulmonary vein isolation with zero reported complications.
Why the study?
The first clinical use of the POLARx cryoballoon catheter for pulmonary vein isolation in patients with atrial fibrillation in the Russian Federation was reported.
Case Report (n=3)
No
The POLARx cryoballoon catheter represents a feasible and safe tool for achieving acute pulmonary vein isolation in patients with atrial fibrillation.
Answers are grounded in this paper and cite their sources.
Initial experience suggests POLARx enables safe acute PVI; hypothesis-generating and should not yet alter practice.
There is the first clinical use of POLARx cryoballoon catheter for pulmonary vein isolation in patients with atrial fibrillation in Russian Federation.
No takes yet. Share an insight, caveat, or question.
Artyukhina et al. (2022) conducted a case report in Atrial fibrillation (n=3). POLARx cryoballoon catheter was evaluated on Acute pulmonary vein isolation. The POLARx cryoballoon catheter achieved acute pulmonary vein isolation in 100% of the treated cases with no intra- or postoperative complications.
Synapse has enriched 10 related papers. Consider them for comparative context: